GLP-1 RAs (like Ozempic and Wegovy ) and dual GLP-1/GIP RAs (like Mounjaro and Zepbound ) mimic natural gut hormones
This proximity drives AR-dependent transcriptional regulation and cytostasis, specifically in AR+ cell lines
GLP-1RAs as a support for MCAS For some basics: glucagon-like peptide-1 receptor agonists (abbreviated as GLP-1 medications or as I noted above, GLP-1RAs) are a class of medications that includes semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound, which also work on GIP receptors), as well as in-trials Retatrutide (a triple agonist that works on GLP-1, GIP, and Glucagon receptors)
Why is this list so focused on easy foods
Rare but nevertheless serious side effects that might appear after the administration of the product include: Trouble swallowing
Understanding Retatrutide for Weight Loss Retatrutide is gaining attention as a potential breakthrough in weight loss medication, though it remains in the clinical trial phase and has yet to receive FDA approval